Published in Nat Rev Cancer on February 24, 2012
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med (2016) 1.69
The role of the myofibroblast in tumor stroma remodeling. Cell Adh Migr (2012) 1.46
Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol (2012) 1.45
The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng (2014) 1.40
Immunological hallmarks of stromal cells in the tumour microenvironment. Nat Rev Immunol (2015) 1.24
Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. J Immunol (2012) 1.15
Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4⁺ T cell tolerance. J Exp Med (2014) 1.08
Interstitial fluid flow and drug delivery in vascularized tumors: a computational model. PLoS One (2013) 1.03
Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors. New J Phys (2013) 0.99
Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells. J Immunol (2014) 0.97
Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol (2013) 0.95
Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis. PLoS One (2013) 0.93
Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways? Front Oncol (2012) 0.93
Interstitial fluid flow: the mechanical environment of cells and foundation of meridians. Evid Based Complement Alternat Med (2012) 0.92
Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells. Am J Physiol Cell Physiol (2013) 0.90
Role of constitutive behavior and tumor-host mechanical interactions in the state of stress and growth of solid tumors. PLoS One (2014) 0.90
Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo. Clin Cancer Res (2013) 0.90
Lymphatic function and immune regulation in health and disease. Lymphat Res Biol (2013) 0.89
Lymphatic vessels in health and disease. Wiley Interdiscip Rev Syst Biol Med (2012) 0.88
Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area. Oncotarget (2015) 0.87
Biomimetic tumor microenvironment on a microfluidic platform. Biomicrofluidics (2013) 0.86
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discov (2015) 0.85
Biomaterials for enhancing anti-cancer immunity. Curr Opin Biotechnol (2016) 0.85
Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy. MBio (2015) 0.84
Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis. Angiogenesis (2013) 0.84
Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspective. Biomed Microdevices (2013) 0.84
Toluene diisocyanate (TDI) disposition and co-localization of immune cells in hair follicles. Toxicol Sci (2014) 0.84
Modeling tumor microenvironments in vitro. J Biomech Eng (2014) 0.84
Lymph node biophysical remodeling is associated with melanoma lymphatic drainage. FASEB J (2015) 0.84
Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical study. BMC Cancer (2014) 0.84
Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications. Front Immunol (2015) 0.83
Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment. Expert Rev Mol Med (2015) 0.83
Lymphatic system: an active pathway for immune protection. Semin Cell Dev Biol (2014) 0.83
Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest (2016) 0.82
Cellular control of connective tissue matrix tension. J Cell Biochem (2013) 0.82
Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasis. Neoplasia (2014) 0.82
Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer. Cancer Discov (2015) 0.81
FOXP3+ lymphocyte density in pancreatic cancer correlates with lymph node metastasis. PLoS One (2014) 0.81
Inflammation-induced lymphangiogenesis and lymphatic dysfunction. Angiogenesis (2014) 0.81
Cancer cell glycocalyx mediates mechanotransduction and flow-regulated invasion. Integr Biol (Camb) (2013) 0.81
Engineered three-dimensional microfluidic device for interrogating cell-cell interactions in the tumor microenvironment. Biomicrofluidics (2014) 0.81
Progression of carcinogen-induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics. Int J Cancer (2013) 0.80
Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications. Front Oncol (2015) 0.79
Temporal characterization of lymphatic metastasis in an orthotopic mouse model of oral cancer. Head Neck (2014) 0.79
In vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis. PLoS One (2013) 0.79
(Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia. Exp Mol Med (2014) 0.78
The Lymphatic System: Integral Roles in Immunity. Annu Rev Immunol (2016) 0.78
Cell culture conditions: from outer space-like conditions to the mimicking of complex in vivo environments. J Appl Oral Sci (2014) 0.78
Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy. Genes Chromosomes Cancer (2015) 0.78
A contact line pinning based microfluidic platform for modelling physiological flows. Lab Chip (2013) 0.78
Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip. Cancer Lett (2015) 0.78
Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice. Oral Oncol (2013) 0.77
Lamin A/C deficiency reduces circulating tumor cell resistance to fluid shear stress. Am J Physiol Cell Physiol (2015) 0.77
Hyaluronan-Derived Swelling of Solid Tumors, the Contribution of Collagen and Cancer Cells, and Implications for Cancer Therapy. Neoplasia (2016) 0.77
Exploring the tumor microenvironment with nanoparticles. Cancer Treat Res (2015) 0.77
Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells. Oncotarget (2016) 0.77
Phytochemicals Approach for Developing Cancer Immunotherapeutics. Front Pharmacol (2017) 0.76
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis. Oncoimmunology (2015) 0.76
Inflammatory lymphangiogenesis in postpartum breast tissue remodeling. J Clin Invest (2014) 0.76
Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model. J Control Release (2015) 0.76
CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients. Oncoimmunology (2016) 0.75
Shaping of Peripheral T Cell Responses by Lymphatic Endothelial Cells. Front Immunol (2017) 0.75
Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis. Nat Commun (2017) 0.75
Multistep, effective drug distribution within solid tumors. Oncotarget (2015) 0.75
Monitoring of Blood Vessel Density Using Contrast-Enhanced High Frequency Ultrasound May Facilitate Early Diagnosis of Lymph Node Metastasis. J Cancer (2017) 0.75
A Clinico-Pathological Study of Cervical Lymph Nodes. Indian J Otolaryngol Head Neck Surg (2016) 0.75
Optimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model. Sci Rep (2017) 0.75
A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer. Oncoimmunology (2017) 0.75
The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment. Front Immunol (2016) 0.75
A robust in vitro model for trans-lymphatic endothelial migration. Sci Rep (2017) 0.75
Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses. Int J Mol Sci (2016) 0.75
Fluid shear stress activates YAP1 to promote cancer cell motility. Nat Commun (2017) 0.75
Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Sci Rep (2016) 0.75
The Role of Lymphatic Endothelial Cells in Liver Injury and Tumor Development. Front Immunol (2016) 0.75
Early diagnosis of lymph node metastasis: Importance of intranodal pressures. Cancer Sci (2016) 0.75
Fabrication of 3D Biomimetic Microfluidic Networks in Hydrogels. Adv Healthc Mater (2016) 0.75
Cancer associated fibroblasts: An essential role in the tumor microenvironment. Oncol Lett (2017) 0.75
Vasculature-On-A-Chip for In Vitro Disease Models. Bioengineering (Basel) (2017) 0.75
Elastographic Assessment of Xenograft Pancreatic Tumors. Ultrasound Med Biol (2017) 0.75
Model of Vascular Desmoplastic Multispecies Tumor Growth. J Theor Biol (2017) 0.75
Vascular Mechanobiology: Towards Control of In Situ Regeneration. Cells (2017) 0.75
Tumor Regulation of Lymph Node Lymphatic Sinus Growth and Lymph Flow in Mice and in Humans. Yale J Biol Med (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 25.96
Tensional homeostasis and the malignant phenotype. Cancer Cell (2005) 19.30
Fibroblasts in cancer. Nat Rev Cancer (2006) 18.95
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 18.20
Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell (2009) 14.40
Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol (2009) 9.87
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol (2007) 7.20
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell (2008) 6.78
Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med (2006) 6.44
High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer (2004) 5.99
Lymphangiogenesis: Molecular mechanisms and future promise. Cell (2010) 5.84
Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol (2007) 5.60
CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol (2008) 5.35
Collagen density promotes mammary tumor initiation and progression. BMC Med (2008) 5.13
Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest (2007) 5.05
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature (2007) 4.88
The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity (2005) 4.72
Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol (2002) 4.66
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature (2011) 4.57
Roles of TGFbeta in metastasis. Cell Res (2009) 4.35
Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer (2008) 4.27
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature (2011) 4.07
B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity (2006) 4.04
Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol (2011) 3.87
Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res (2011) 3.73
Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol (2011) 3.70
Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med (2005) 3.64
The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol (2010) 3.57
Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. Biophys J (2008) 3.49
Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell (2011) 3.37
Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients. J Clin Invest (2011) 3.28
Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol (2004) 3.19
The who, how and where of antigen presentation to B cells. Nat Rev Immunol (2009) 3.12
Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science (2010) 3.08
Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol (2003) 3.03
Tumour immunity: effector response to tumour and role of the microenvironment. Lancet (2008) 2.94
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol (2001) 2.89
The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol (2011) 2.83
Interstitial flow as a guide for lymphangiogenesis. Circ Res (2003) 2.82
Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med (2002) 2.78
Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem (2007) 2.67
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood (2006) 2.66
Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci U S A (1989) 2.61
Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell (2007) 2.48
Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med (2010) 2.44
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev (2010) 2.41
Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol (2007) 2.40
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med (2007) 2.39
Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J Exp Med (2010) 2.37
Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood (2009) 2.30
Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat Rev Cancer (2008) 2.12
Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci (2005) 2.07
Non-linear elasticity of extracellular matrices enables contractile cells to communicate local position and orientation. PLoS One (2009) 2.06
Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev (2009) 1.95
In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1. Blood (2008) 1.94
Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Rev (2009) 1.93
Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev (2010) 1.92
Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci U S A (2011) 1.88
The microanatomy of T-cell responses. Immunol Rev (2008) 1.82
Interstitial flow influences direction of tumor cell migration through competing mechanisms. Proc Natl Acad Sci U S A (2011) 1.81
VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood (2007) 1.78
Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol (2010) 1.77
T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity (2011) 1.75
Tumor angiogenesis and interstitial hypertension. Cancer Res (1996) 1.63
An important role of lymphatic vessel activation in limiting acute inflammation. Blood (2011) 1.62
Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med (2008) 1.60
Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer (2008) 1.59
Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci U S A (2005) 1.59
The tumor-draining lymph node as an immune-privileged site. Immunol Rev (2006) 1.57
Microglia/macrophages promote glioma progression. Glia (2010) 1.51
VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep (2012) 1.51
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood (2009) 1.50
The role of podoplanin in tumor progression and metastasis. Anticancer Res (2008) 1.48
Lymphangiogenesis and cancer metastasis. J Cell Mol Med (2009) 1.47
Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol (2009) 1.44
Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res (2010) 1.43
Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res (2009) 1.41
Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ Res (2010) 1.41
Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity (2006) 1.40
The influence of afferent lymphatic vessel interruption on vascular addressin expression. J Cell Biol (1991) 1.38
Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. Cancer Res (2008) 1.38
Determinants of leader cells in collective cell migration. Integr Biol (Camb) (2010) 1.37
Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc Res (2004) 1.35
Bulk transfer of fluid in the interstitial compartment of mammary tumors. Cancer Res (1975) 1.34
Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J Immunol (2009) 1.33
Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment. J Immunol (2009) 1.30
Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integr Biol (Camb) (2011) 1.28
Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am J Pathol (2009) 1.28
Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model. Am J Physiol Heart Circ Physiol (2003) 1.27
Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur J Immunol (2007) 1.23
Lymph node stroma broaden the peripheral tolerance paradigm. Trends Immunol (2010) 1.22
Interstitial fluid pressure in DMBA-induced rat mammary tumours. Scand J Clin Lab Invest (1982) 1.20
The conduit system of the lymph node. Int Immunol (2008) 1.18
Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1. Am J Physiol Heart Circ Physiol (2009) 1.18
Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Res (2011) 1.16
The contribution of B cells to renal interstitial inflammation. Am J Pathol (2007) 1.14
Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. Am J Pathol (2010) 1.13
Encapsulation of adult human mesenchymal stem cells within collagen-agarose microenvironments. Biotechnol Bioeng (2005) 1.25
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials (2013) 1.13
Gelatin microspheres crosslinked with genipin for local delivery of growth factors. J Tissue Eng Regen Med (2010) 1.07
Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis. PLoS One (2013) 0.98
Quantification of three-dimensional cell-mediated collagen remodeling using graph theory. PLoS One (2010) 0.87
Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest (2016) 0.82